VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VTYX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VTYXVentyx Biosciences, Inc.
$14.00$999M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVTYXQuarterly Financials

Ventyx Biosciences, Inc. (VTYX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ventyx Biosciences, Inc. (VTYX) quarterly income statement — complete revenue, gross profit & net income history

VTYX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000316K408K0000000000000
COGS % of Revenue--------------------
Gross Profit00000-316K-408K0000000000000
Gross Margin %--------------------
Gross Profit Growth %-100%100%-----------------
Operating Expenses24.87M29.33M30.1M32.42M38.55M35.4M41.36M50.35M57.95M57.15M42.55M38.57M31.42M20.4M22.75M17.83M12.79M11.19M25.35M1.44M
OpEx % of Revenue--------------------
Selling, General & Admin7.17M7.07M7.2M7.6M7.92M7.59M7.61M8.33M8.2M8.59M7.12M8.39M5.95M5.72M5.34M4M2.24M1.68M747K133K
SG&A % of Revenue--------------------
Research & Development17.71M22.27M22.9M24.82M30.63M27.8M33.75M42.02M49.75M48.56M35.44M30.18M25.47M14.68M17.41M13.82M10.54M9.51M24.6M1.31M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-24.87M-29.33M-30.1M-32.42M-38.55M-35.71M-41.77M-50.35M-57.95M-57.15M-42.55M-38.57M-31.42M-20.4M-22.75M-17.83M-12.79M-11.19M-25.35M-1.44M
Operating Margin %--------------------
Operating Income Growth %35.48%17.86%27.94%35.61%33.47%37.51%1.84%-30.53%-84.44%-180.15%-87.07%-116.38%-145.72%-82.35%10.26%-1137.92%---1402.55%-
EBITDA-24.81M-29.01M-29.74M-32.1M-38.24M-35.4M-41.36M-49.94M-57.69M-57.01M-42.42M-38.42M-31.29M-20.3M-22.66M-17.81M-12.78M-11.18M-25.35M-16.55M
EBITDA Margin %--------------------
EBITDA Growth %35.12%18.04%28.09%35.72%33.7%37.91%2.49%-29.99%-84.34%-180.89%-87.22%-115.73%-144.9%-81.5%10.61%-7.62%----
D&A (Non-Cash Add-back)61K323K356K315K309K316K408K403K265K139K134K150K127K103K90K16K9K4K1K0
EBIT-22.83M-29.33M-30.1M-32.42M-38.55M-35.71M-41.77M-50.35M-57.95M-57.15M-42.55M-35.21M-31.42M-20.4M-22.75M-17.77M-12.77M-15.56M-37.55M-16.55M
Net Interest Income2.06M2.37M2.67M3.06M3.35M3.78M3.23M3.62M3.93M3.9M3.62M3.19M1.01M342K132K000-99K-153K
Interest Income2.06M2.37M2.67M3.06M3.35M3.78M3.23M3.62M3.93M3.9M3.62M3.19M1.01M342K132K00000
Interest Expense00000000000000000099K153K
Other Income/Expense2.04M2.35M2.66M3.07M3.3M3.76M3.2M3.59M3.92M3.89M3.62M3.36M958K380K15K58K13K-4.37M-12.3M-15.26M
Pretax Income-22.83M-26.99M-27.44M-29.35M-35.25M-31.95M-38.57M-46.75M-54.03M-53.25M-38.93M-35.21M-30.46M-20.02M-22.73M-17.77M-12.77M-15.56M-37.65M-16.7M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-22.83M-26.99M-27.44M-29.35M-35.25M-31.95M-38.57M-46.75M-54.03M-53.25M-38.93M-35.21M-30.46M-20.02M-22.73M-17.77M-12.77M-15.56M-37.65M-16.7M
Net Margin %--------------------
Net Income Growth %35.23%15.53%28.86%37.22%34.76%40%0.92%-32.77%-77.36%-166.02%-71.26%-98.19%-138.47%-28.66%39.61%-6.38%---1644.44%-
Net Income (Continuing)-22.83M-26.99M-27.44M-29.35M-35.25M-31.95M-38.57M-46.75M-54.03M-53.25M-38.93M-35.21M-30.46M-20.02M-22.73M-17.77M-12.77M-15.56M-37.65M-16.7M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.32-0.38-0.39-0.41-0.50-0.45-0.62-0.79-0.92-0.91-0.61-0.62-0.57-0.39-0.45-0.38-0.27-0.32-0.77-0.34
EPS Growth %36%15.56%37.1%48.1%45.65%50.55%-1.64%-27.42%-61.4%-133.33%-35.56%-63.16%-111.11%-21.88%41.56%-11.76%--30%-
EPS (Basic)-0.32-0.38-0.39-0.41-0.50-0.45-0.62-0.79-0.92-0.91-0.61-0.62-0.57-0.39-0.45-0.38-0.27-0.32-0.77-0.34
Diluted Shares Outstanding71.3M71.2M71.13M70.81M70.67M70.55M61.83M59.08M58.88M58.56M57.64M56.72M51.67M50.85M50.59M47.27M47.27M48.78M48.78M48.78M
Basic Shares Outstanding71.3M71.2M71.13M70.81M70.67M70.55M61.83M59.08M58.88M58.56M57.64M56.72M51.67M50.85M50.59M47.27M47.27M48.78M48.78M48.78M
Dividend Payout Ratio--------------------